Nordic-American Healthcare Conference 2023

DNB Markets Session - December 7th

The DNB//Back Bay Partnership for healthcare growth is pleased to present the best publicly-traded Nordic biopharma and medical technology companies focused in areas with high patient needs, including cancer, GI, metabolism, neurology, rare diseases, transplantation, vaccines, and others. In addition, come hear from our expert panel on the current state of the Global Healthcare Capital Markets and where we are headed.

  • Presentations by Nordic public companies
  • Expert panel discussion: Global Healthcare Capital Markets - Where are we and where are we headed?

Book One-on-One meetings:

Institutional investors can request 1:1 meetings with the companies attending the conference. Please register first, and you will see the list of companies available for one-on-one meetings.

We will come back to you as soon as possible with a proposed schedule.

Register here

We are proud to present these Nordic companies:

Alligator-500x400

Alligator Bioscience

Only available for 1:1 meetings.

  • Company page
AlkAbello-500x400

ALK Bello

Alvotech-500x400

Alvotech

BavarianNordic-500x400

Bavarian Nordic

Bioarttic-500x400

Bioarctic

Calliditas-500x400

Calliditas Therapeutics

Lundbeck-500x400

Lundbeck

NovoNordisk-500x400

Novo Nordisk

Sobi-500x400
Xvivo-500x400

XVIVO Perfusion

Ultimovacs-mhvitt

Ultimovacs

Footer navigation

Head office

Dronning Eufemias gate 30

0191 Oslo, Norway

Postal address

DNB

PO Box 1600 - Sentrum

0021 Oslo

Org. no.

DNB Bank ASA

984 851 006

DNB Websites

DNB Eiendom (DNB Real Estate)#girlsinvestDNB Tech Blog

International

DNB LuxembourgDNB SwedenDNB Denmark

Social media

FacebookYouTube
Terms of useData protectionCookiesPrice listCompare our prices with other companies at Finansportalen.noWork for us

© DNB